XML 36 R11.htm IDEA: XBRL DOCUMENT
v3.23.3

Supplemental Financial Data | 9 Months Ended
--- | ---
Sep. 30, 2023
Supplemental Financial Data [Abstract] |
Supplemental Financial Data | 3. Supplemental Financial Data Inventories Our inventory consisted of the following (in thousands):
|  | September 30, 2023 |  |  | December 31, 2022 |
Raw materials: |  |  |  |  |  |
Raw materials - clinical |  | $ | 18,427 |  |  | $ | 17,061 |
Raw materials - commercial |  |  | 4,380 |  |  |  | 2,699 |
Total raw materials |  |  | 22,807 |  |  |  | 19,760 |
Work in process |  |  | 2,651 |  |  |  | 2,109 |
Finished goods |  |  | 176 |  |  |  | 164 |
Total inventory |  | $ | 25,634 |  |  | $ | 22,033 |
Accrued Liabilities Our accrued liabilities consisted of the following (in thousands):
|  | September 30, 2023 |  |  | December 31, 2022 |
Clinical development expenses |  | $ | 89,217 |  |  | $ | 116,460 |
In-licensing expenses |  |  | 7,560 |  |  |  | 7,945 |
Commercial expenses |  |  | 8,575 |  |  |  | 3,498 |
Other miscellaneous expenses |  |  | 13,616 |  |  |  | 12,198 |
Total accrued liabilities |  | $ | 118,968 |  |  | $ | 140,101 |

X
- References No definition available. + Details
Name: | ions_SupplementalFinancialDataAbstract
Namespace Prefix: | ions_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration